Milk; Colostrum Patents (Class 530/832)
-
Patent number: 5340924Abstract: A method for treatment of a matter which contains moisturized or liquified lactoferrin which has been isolated from mammalian milk, processed mammalian milk and by-products in mammalian milk-processing, without losing the physiological activities of lactoferrin, which comprises adjusting pH of said moisturized or liquefied lactoferrin contained in said matter within an acidic range between 2.0 and 6.0 both inclusive by adding acid or aqueous solution of acid when the pH of said moisturized or liquefied lactoferrin is out of said pH range, and heating said matter in the range from 60.degree. C. to 130.degree. C. for a span of time which may assure 60% or more of undenaturization rate of lactoferrin.Type: GrantFiled: March 27, 1992Date of Patent: August 23, 1994Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Mamoru Tomita, Yoshitaka Tamura, Hiroshi Miyakawa, Hitoshi Saito, Hiroaki Abe, Eiji Nagao
-
Patent number: 5322836Abstract: Bioactive agents, having growth-promoting activity upon Bifidobacteria, consisting of one or more lactoferrin-compounds selected from the group consisting of bovine lactoferrin, bovine apolactoferrin and bovine Fe-lactoferrin, which can be used as it is as agents to promote proliferation of Bifidobacteria both in vivo and in vitro, and as additives to prepare compositions, materials and products to afford growth-promoting activity thereto, and to improve survivability of Bifidobacteria, if contained therein.Type: GrantFiled: March 6, 1991Date of Patent: June 21, 1994Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Mamoru Tomita, Seiichi Shimamura, Yasuo Fukuwatari, Hiroshi Miyakawa, Hitoshi Saito
-
Patent number: 5314873Abstract: A milk-protein hydrolyzate consisting of a mixture of peptides and free amino acids having proliferation activating property on human cutaneous cells but not having antigenicity of the milk-protein may be obtained by enzymatic hydrolysis of milk protein. The peptides of the hydrolyzate have molecular weights less than 1000 daltons, and the hydrolyzate has a free aromatic amino acid/total aromatic amino acid ratio of at least 90%. Fractionation of the milk protein hydrolyzate yields a fraction consisting of a mixture of peptides. The fraction has a proliferation activating property on human cutaneous cells but does not have the antigenicity of the milk protein. The fraction contains aromatic amino acids in an amount of less than 5% by weight of total amino acids. Both the hydrolyzate and the fraction can be formulated into cosmetic compositions for application to the hair and skin.Type: GrantFiled: May 17, 1991Date of Patent: May 24, 1994Assignees: Morinaga Milk Industry Co., Ltd., Iwase Cosfa Co., Ltd.Inventors: Mamoru Tomita, Takesi Kitazawa, Seiji Kawaura, Yasuo Fukuwatari, Masanobu Nojiri
-
Patent number: 5310877Abstract: The invention is directed to a method for the separation of gamma globulin from albumin contained in an aqueous solution of both having a pH of 8-10 by ultrafiltration using an altered substrate microfilter having a water permeability of no more than 20 gallons per square foot per day per pound per square inch.Type: GrantFiled: April 8, 1993Date of Patent: May 10, 1994Assignee: E. I. Du Pont de Nemours and CompanyInventor: Harold G. Spencer
-
Patent number: 5272255Abstract: IgE binding factors (IgE-bfs) with IgE suppressor (IgE-SF) activity obtainable from human colostrum in an enriched form, a method for the prevention and/or the treatment of allergy by administering the IgE-bfs and pharmaceutical compositions comprising said IgE-bfs.Type: GrantFiled: April 22, 1992Date of Patent: December 21, 1993Assignee: Ciba-Geigy CorporationInventor: Guy Delespesse
-
Patent number: 5266685Abstract: New protein hydrolyzates are produced by treating an aqueous solution of a protein hydrolyzate with an adsorptive resin functional to remove from the protein hydrolyzate bitter taste components, color and odor components and aromatic amino acids. The treated protein hydrolyzate solutions can be concentrated and dried if desired to powder form.Type: GrantFiled: May 5, 1992Date of Patent: November 30, 1993Assignee: Grain Processing CorporationInventor: John T. Garbutt
-
Patent number: 5198419Abstract: Lactoferrin can be used to increase the efficacy of beta-lactam antibiotics. There is a potentiating effect when lactoferrin is administered either simultaneous with or shortly before or after the administration of beta-lactam antibiotics. The dosage of lactoferrin administered is usually 0.5-100 mg/kg and preferably 1-10 mg/kg.Type: GrantFiled: October 4, 1991Date of Patent: March 30, 1993Assignee: Immuno Japan Inc.Inventors: Kunio Ando, Sachiko Goto
-
Patent number: 5185157Abstract: A method of treating a human patient with refractory Eosinophilia Myalgia Syndrome via oral administration of an effective dosage range of from 1000 mg. to 3000 mg. of a pharmaceutical composition, in unit dosage form, comprising a minor amount of a solid or liquid carrier and a major amount of the amino acid, pharmaceutical grade L-tryptophan, or its acid addition salt, with both of the carriers and the amino acid to be selected to exclude the zinc, magnesium, and calcium containing salts as adjuvants.Type: GrantFiled: May 2, 1990Date of Patent: February 9, 1993Inventor: John C. Caston
-
Patent number: 5171845Abstract: The invention concerns a new protein of approximately 17 KD, with angiogenic activity, a process for isolating it from mammalian milk, therapeutic compositions containing it, a process for detecting and/or determining the content of mammalian angiogenins, their homologues and their fragments. Said protein, of bovine origin, has a sequence of 125 aminoacids, 81 of which are common to human angiogenin, and a molecular weight of approximately 17 KD, and is extracted from mammalian milk. Application to the detection of mammalian angiogenin.Type: GrantFiled: August 21, 1989Date of Patent: December 15, 1992Inventors: Genevieve Spik, Andre Tarjar, Jean Montreuil
-
Patent number: 5166132Abstract: A topical use pharmaceutical composition and a process for its preparation, comprising an improved enzyme-modified casein sol. Prior to being enzyme-modified, the casein is solubilized and neutralized by an alkali solution containing a molar weight percent ratio in the range of from 90:10 to 100:0, potassium hydroxide to sodium hydroxide. Said neutralization occurring for a time in the range of 5 to 35 minutes to allow for complete neutralization of the casein. The neutralized casein is then hydrolyzed or modified by enzymatic digestion by a proteolytic enzyme for a time sufficient to achieve a weight ratio of protein nitrogen to amino nitrogen in the range from 7:1 to 9:1. The improved enzyme-modified casein sol may then be mixed with stabilizing and pressuring agents, such as carrageenan, polyvinyl pyrrolidone, methyl paraben or propyl paraben.Type: GrantFiled: March 23, 1989Date of Patent: November 24, 1992Inventor: Arthur L. Gordon
-
Patent number: 5106618Abstract: The invention comprises treatment of gastrointestinal disorders of parasitic protozoan and bacterial origin in immunocompromised and immunocompetent animals by administration hyperimmune milk products.Type: GrantFiled: May 22, 1989Date of Patent: April 21, 1992Assignee: Stolle Research and Development CorporationInventors: Lee R. Beck, Donald P. Kotler
-
Patent number: 5059680Abstract: A preparation of an isolated immunoreactive CA 125 Antigen, and a method of isolating it is disclosed. CA 125 Antigen is a glycoprotein having a molecular weight of about 200kD, and a carbohydrate-content of about 24%. The CA 125 Antigen is isolated from a cell culture medium by acid precipitation, and is subsequently purified by size exclusion chromatography and immunoaffinity chromatography.Type: GrantFiled: November 24, 1986Date of Patent: October 22, 1991Assignee: Centocor, Inc.Inventors: Hugh M. Davis, Thomas L. Klug, Vincent R. Zurawski, Jr.
-
Patent number: 5055558Abstract: A method for the selective extraction of beta-lactoglobulin and other proteins from whey or milk by means of subunit exchange chromatography and for the deproteinization of whey by subsequent chromatography on an ion exchange resin.Type: GrantFiled: March 25, 1988Date of Patent: October 8, 1991Assignee: Consiglio Nazionale Della RicercheInventors: Emilia Chiancone, Maurizio Gattoni
-
Patent number: 4997914Abstract: A method for separating and purifying lactoferrin from milk is disclosed, which method comprises the steps of bringing raw milk containing lactoferrin into contact with a sulfuric ester of a crosslinked polysaccharide so that lactoferrin may be adsorbed by the sulfuric ester, and then eluting the adsorbed lactoferrin. The elution of the adsorbed lactoferrin is preferably conducted by the use of a buffer solution containing a 0.4-1.5 M aqueous sodium chloride solution.Type: GrantFiled: November 9, 1988Date of Patent: March 5, 1991Assignee: Snow Brand Milk Products Co., Ltd.Inventors: Hiroshi Kawakami, Morimasa Tanimoto, Shunichi Dousako
-
Patent number: 4994496Abstract: This invention relates to a carrier for the transport of drugs in a mammalian system comprising milk fat globules.Type: GrantFiled: September 9, 1987Date of Patent: February 19, 1991Inventors: Elizabeth A. Repasky, Richard B. Bankert
-
Patent number: 4980450Abstract: The method consists in subjecting the raw material (milk or retentate) to enzymatic hydrolysis by means of at least one proteolytic enzyme able to reproduce the proteic digestion occuring in vivo in the human body; recovering the thus obtained hydrolyzate; subjecting the latter to at least one ultrafiltration step on membranes able to retaining the phosphopeptides while letting the peptides pass therethrough, the ultrafiltrate thus containing the non phosphorylated peptides; recovering the ultrafiltration retentate; disaggregating the phosphopeptides in the retentate; and subjecting the latter to at least one further ultrafiltration step on membranes which do not retain the phosphopeptides, these being thus separated from the enzyme and available to be recovered as product. The resulting products are useful as dietetic aliments, therapeutic nutriments or medicaments.Type: GrantFiled: May 15, 1985Date of Patent: December 25, 1990Assignee: Institut National de la Recherche AgronomiqueInventors: Gerard Brule, Loic Roger, Jacques Fauquant, Michel Piot
-
Patent number: 4906616Abstract: A medicinal composition, particularly but not exclusively for use in fluids for medical dialysis, contains, as an agent for maintaining the osmolality of the fluid, a protein hydrolysate resulting from the action of a proteolytic enzyme on the sodium caseinate fraction of milk protein. The enzyme is preferably trypsin but other proteolytic enzymes and enzyme mixtures may be used, examples being chymotrypsin, pancreatin and pronase.The method of production involves treating the sodium caseinate in aqueous medium with the enzyme at the appropriate pH and temperature for optimum enzyme activity. The product of the enzymic hydrolysis, after filtration through a bacterial filter, adjustment of the osmolality to an appropriate level of around 300 mOsm/Kg and the pH to physiological level of about 6.6 and addition of physiological salt levels, constitutes the final product.Type: GrantFiled: February 6, 1989Date of Patent: March 6, 1990Inventors: Thomas Gilchrist, William Manson
-
Patent number: 4873316Abstract: This invention relates to the production of recombinant proteins in mammals' milk. Particularly, this invention relates to an expression system comprising the mammal's casein promoter which when transgenically incorporated into a mammal permits the female species of that mammal to produce the desired recombinant protein in or along with its milk. This invention also relates to the transgenic mammal that produces the desired recombinant product in its milk.Type: GrantFiled: June 23, 1987Date of Patent: October 10, 1989Assignee: Biogen, Inc.Inventors: Harry Meade, Nils Lonberg
-
Patent number: 4866037Abstract: IgE binding factors (IgE-bfs) with IgE suppressor (IgE-SF) activity obtainable from human colostrum in an enriched form, a method for the prevention and/or the treatment of allergy by administering the IgE-bfs and pharmaceutical compositions comprising said IgE-bfs.Type: GrantFiled: January 17, 1986Date of Patent: September 12, 1989Assignee: Ciba-Geigy CorporationInventor: Guy Delespesse
-
Patent number: 4843065Abstract: A method of preparing remedies for the treatment of bacterial and viral infections which involves introduction into the udder of an ungulate during lactation, a specific vaccine comprising bacterial and/or viral organisms in an inactive state, and the preparation of small dosages of the secretary fluid subsequently withdrawn during lactation from the ungulate thus treated.Type: GrantFiled: October 13, 1987Date of Patent: June 27, 1989Inventors: Robert A. Collins, Philip F. Weighner
-
Patent number: 4791193Abstract: A process for producing bovine lactoferrin in high purity form raw milk-materials containing skim milk or whey originated form cow's milk which comprises: adsoption step wherein said raw materials are contacted, at a temperature between 0.degree.-60.degree. C., with weakly acidic cation-exchanger which includes carboxymethyl groups as ion exchanging groups and has haemoglobin adsorption property more than 3.5 g/100 ml; rinsing step wherein said exchanger is washed with water to remove substances other than those adsorbed to said exchanger; and desorption step wherein the substances adsorbed to said exchanger are desorbed therefrom with a solution of one or more of salts to thereby yield highly purified bovine lactoferrin without deterirating raw milk materials. Said desorption step can be carried out in a single stage to produce lactoferrin more than 80% purity to total proteins recovered, and in two stage to attain more than 98% purity.Type: GrantFiled: July 16, 1987Date of Patent: December 13, 1988Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Shigeo Okonogi, Mamoru Tomita, Toshio Tomimura, Yoshitaka Tamura, Teruhiko Mizota
-
Patent number: 4784850Abstract: The present invention relates to a process for the manufacture of a preparation containing specific antibodies against the K-99 antigen of various strains of enterotoxigenic Escherichia coli (etec). In said process the milk obtained from postpartum cows, which had been previously vaccinated with E. coli strain 168, is clotted with a suitable enzyme. The fatty serum is then separated from the cheese obtained, the fat is then separated out, the fat-free serum is then subjected to ultrafiltration through a suitable number of appropriate membranes so that 30-50% of the water present is removed the retentate is then sterilized. Suitable membranes are those which are permeable only to molecules of less than about 22,000-30,000 daltons molecular weight. The preparation is advantageously lyophilized and the lyophilized preparation is subsequently sterilized by irridation, e.g. with Co.sup.60.Type: GrantFiled: September 4, 1985Date of Patent: November 15, 1988Assignee: Mutzarei MaabarotInventor: Gilead B. Abraham
-
Patent number: 4777243Abstract: New immunostimulant substances are obtained by hydrolysing delipidized bovine casein with a proteolytic enzyme and fractionating the product.Type: GrantFiled: June 14, 1985Date of Patent: October 11, 1988Assignee: Rhone Poulenc Sante, French Body CorporateInventors: Pierre Jolles, Daniele Migliore-Samour, Fabienne Parker
-
Patent number: 4749567Abstract: A product and method for increasing fertility in sheep. By "increasing felity" is meant increasing the potential of a flock of sheep to multiply by increasing ovulation in ewes. The product is an immunogenic conjugate of 4-androstene-3, 17-dione and a soluble milk protein (SMP): 6-hydroxyandrost-4-ene-3, 17-dione 6-hemisuccinyl: SMP. The method comprises immunizing the ewes in a flock of sheep against 4-androstene-3, 17-dione by administering 6-hydroxyandrost-4-ene-3, 17-dione 6-hemisuccinyl SMP at the rate of 3 to 5 mg per ewe. In previously untreated ewes, two administrations are required at between 8 to 9 and 4 to 5 weeks before the planned commencement of mating. Subsequent administrations are annually and are recommended at 5 weeks before the commencement of mating.Type: GrantFiled: October 24, 1986Date of Patent: June 7, 1988Assignee: The Director General of the Ministry of Agriculture and FisheriesInventors: Kenneth P. McNatty, Anton F. Erasmuson, Douglas R. Crump
-
Patent number: 4691011Abstract: According to the invention, a milk protein product is provided. The milk protein product has water-dispersible and hydrophilic properties and contains substantially no serum. The milk protein product is obtained by coagulating milk under a flowing condition at a predertermined pH-temperature range to obtain a coagulum and then separating the coagulum.Type: GrantFiled: December 16, 1985Date of Patent: September 1, 1987Assignee: The Calpis Food Industry Co., Ltd.Inventors: Kaoru Inagami, Noboru Kikuchi
-
Patent number: 4668771Abstract: This invention discloses a method for separating a highly pure form of bovine lactoferrin from cow's milk and purifying same which comprises preparing an affinity-chromatographic column by fixing a monoclonal antibody against bovine lactoferrin to an insoluble carrier; passing milk or a solution of bovine lactoferrin derived from cow'milk through the affinity-chromatographic column; and then eluting the bovine lactoferrin adsorbed to the affinity-chromatographic column.Type: GrantFiled: December 13, 1985Date of Patent: May 26, 1987Assignee: Snow Brand Milk Products Co., Ltd.Inventors: Hiroshi Kawakami, Hiroshi Shinmoto, Shunichi Dosako, Kenkichi Ahiko
-
Patent number: 4667018Abstract: A process for the purification of proteins from a fluid medium wherein said proteins have an isoelectric pH higher than the pH of said fluid medium, said process comprising passing the liquid medium over acidic polysaccharide gel particles of at least 0.5 mm in the shortest dimension, and recovering the desired proteins from the gel particles by elution with an aqueous salt solution having ions concentration of at least 5 grams per liter.Type: GrantFiled: February 6, 1986Date of Patent: May 19, 1987Assignee: Oleofins, S.A.Inventors: Jean-Paul Prieels, Robert Peiffer
-
Patent number: 4644056Abstract: A method of preparing a solution of lactic or colostric immunoglobulins or both by processing milk or colostrum or both accompanied by precipitation of the caseins, characterized in that milk or colostrum or both are acidified to a pH of 4.0-5.5, subjected to cross-flow filtration in a filtration unit with a mean pore size of 0.1-1.2 .mu.m, and the low-molecular components removed by means of further cross-flow filtration in another filtration unit with a limit of separation of 5 000-80 000 daltons, as well as an agent for treating bacterial and viral infections that consists of a solution obtained by means of said method.Type: GrantFiled: September 3, 1985Date of Patent: February 17, 1987Assignee: Biotest Pharma GmbHInventors: Norbert Kothe, Herbert Dichtelmuller, Wolfgang Stephan, Bertram Eichentopf
-
Patent number: 4623541Abstract: A method for the continuous production of a purified immunoglobulin preparation wherein the antibodies are substantially enriched by means of a selective two-step ammonium sulfate fractionation procedure employing centrifugation and ion depletion processes. The purified immunoglobulins are subsequently commingled with condensed skim milk and spray dried. The resulting product for example is employed in the formulation of milk replacers for artificial rearing of neonatal pigs to provide the passive immunity to disease normally provided by sows' colostrum and later milk.Type: GrantFiled: June 25, 1985Date of Patent: November 18, 1986Assignee: Candian Patents and Development LimitedInventors: James I. Elliot, Gordon E. Timbers, H. Wayne Modler, Robert W. Allen